Part 5/10:
The Influence of Big Pharma and Misinformation
The perception of GLP-1 drugs is further intertwined with skepticism towards big pharmaceutical companies. Many consumers are wary, given the historical context of irresponsible sales tactics and inflated prices for other medications, such as insulin. The cost of OIC can exceed $1,000 per month—a staggering figure that raises questions about accessibility and affordability.
Compounding pharmacies offer alternatives that can be more affordable, but these come with their own risks. Recent investigations suggest that compounded medications can be contaminated or improperly dosed, presenting a significant concern for those considering this route.